Skip to main content
. Author manuscript; available in PMC: 2018 Sep 1.
Published in final edited form as: Alzheimers Dement. 2017 Mar 3;13(9):1024–1030. doi: 10.1016/j.jalz.2017.01.022

Figure 1. Anxiety and Depression Symptoms Before and After Disclosure.

Figure 1

Data at baseline, immediately post-disclosure (day of disclosure), and 6-weeks and 6 months post disclosure on the Center for Epidemiologic Studies Depression (CES-D) scale (Panel A) and the Beck Anxiety Inventory (BAI; Panel B). There was no difference in depressive symptoms across groups over time. A minimal increase in anxiety symptoms was apparent immediately post-disclosure in the amyloid elevated group but was not sustained over time.